Dow Up0.08% Nasdaq Down0.30%

Aratana Therapeutics, Inc. (PETX)

-NGM
10.00 Down 0.03(0.30%) Sep 19, 4:00PM EDT
|After Hours : 10.00 0.00 (0.00%) Sep 19, 4:40PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Net Income (9,278) (9,152) 7,117   (4,671)
Operating Activities, Cash Flows Provided By or Used In
Depreciation617  566  386  3  
Adjustments To Net Income1,448  2,536  (14,550)244  
Changes In Accounts Receivables(241)125   -   -  
Changes In Liabilities(193)(1,787)1,745  (496)
Changes In Inventories1  (70) -   -  
Changes In Other Operating Activities(77)(429)28  2,571  
Total Cash Flow From Operating Activities (7,733) (8,211) (5,267) (2,349)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(179)(67)(80)(6)
Investments741  (367)1,467  (248)
Other Cash flows from Investing Activities(281)(12,951)(30,997)144  
Total Cash Flows From Investing Activities 281   (13,385) (29,610) (110)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock(1,002)90,466  19,805  34,279  
Net Borrowings106  (18,173)9,987   -  
Other Cash Flows from Financing Activities(156)(15,010) -   -  
Total Cash Flows From Financing Activities (1,052) 57,283   29,792   34,279  
Effect Of Exchange Rate Changes32  (28) -   -  
Change In Cash and Cash Equivalents (8,472) 35,659   (5,085) 31,820  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.